ABERRANT IMMUNE LANDSCAPE IN BONE MARROW OF HIGH-RISK MYELODYSPLASTIC SYNDROME PATIENTS

被引：0
|
作者：
Rai, R. [1 ]
Patel, F. [1 ]
Feld, J. [1 ]
Melana, S. [1 ]
Demakos, E. [1 ]
Horowitz, A. [2 ]
Silverman, L. [1 ]
机构：
[1] Tisch Canc Inst, Icahn Sch Med, Hematol Med Oncol, New York, NY USA
[2] Icahn Sch Med, Lipshultz Precis Immunol Inst, Tisch Canc Inst, Dept Oncol Sci, New York, NY USA
来源：
LEUKEMIA RESEARCH | 2023年 / 128卷
关键词：
D O I：
10.1016/j.leukres.2023.107215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P080
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Aberrant Proportion of Monocyte Subsets in Bone Marrow of High-Risk Myelodysplastic Syndrome Patients
    Rai, Richa
    Bigenwald, Camille
    Feld, Jonathan
    Melana, Stella
    Demakos, Erin P.
    Horowitz, Amir
    Silverman, Lewis R.
    BLOOD, 2022, 140 : 11432 - 11433
  • [2] Evidence of Targetable Immune Dysfunction in the Bone Marrow of Patients with Intermediate/High-Risk Myelodysplastic Syndrome Refractory to Hypomethylating Agents
    Green, Cherie
    Yan, Mark
    Nalle, Stefani
    Ma, Connie
    Robert, Alberto
    Zhong, Judy
    Krishnan, Kartik
    Phuong, Patrick
    Byon, John
    Woodard, Paul
    Nemeth, Michael J.
    Griffiths, Elizabeth A.
    Adamkewicz, Joanne I.
    Venstrom, Jeffrey M.
    Dail, Monique
    BLOOD, 2017, 130
  • [3] Profile of Checkpoint Molecules Expression on Bone Marrow Cell Populations in Patients with High-Risk Myelodysplastic Syndrome
    Tcvetkov, Nikolai Yu.
    Morozova, Elena V.
    Epifanovskaya, Olga S.
    Babenko, Elena V.
    Barabanshikova, Maria V.
    Lepik, Kirill V.
    Bakin, Eugene A.
    Vlasova, Julia J.
    Smirnova, Anna G.
    Zander, Axel R.
    Moiseev, Ivan S.
    BLOOD, 2020, 136
  • [4] Bone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes
    Saft, Leonie
    Bjorklund, Elisabet
    Berg, Elisabeth
    Hellstrom-Lindberg, Eva
    Porwit, Anna
    LEUKEMIA RESEARCH, 2013, 37 (03) : 266 - 273
  • [5] Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high-risk myelodysplastic syndrome
    Warny, Marie
    Helby, Jens
    Sengelov, Henrik
    Nordestgaard, Borge G.
    Birgens, Henrik
    Bojesen, Stig E.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (03) : 218 - 226
  • [6] Intensive chemotherapy for patients with high-risk myelodysplastic syndrome
    Beran, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2000, 72 (02) : 139 - 150
  • [7] HIGH-RISK IMMUNOPHENOTYPIC MARKERS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Trubkina, H.
    Krasko, O.
    Smolnikova, V.
    Lendzina, I.
    Iskrou, I.
    LEUKEMIA RESEARCH, 2021, 108 : S42 - S42
  • [8] Day + 100 bone marrow megakaryocyte count predicts transplant outcome in patients with high-risk myelodysplastic syndrome and acute leukemia
    Zeynep Arzu Yegin
    Şeyma Yıldız
    Emine Merve Savaş
    Ali Şeker
    Pınar Uyar Göçün
    Zübeyde Nur Özkurt
    Nalan Akyürek
    Münci Yağcı
    Journal of Hematopathology, 2025, 18 (1)
  • [9] Alteration in immune-effector cells in bone marrow of myelodysplastic syndrome patients
    Alfinito, F.
    Luciano, L.
    Sica, M.
    Milite, F.
    Costagliola, S.
    Terrazzano, G.
    Palladino, G. C.
    Della Pepa, R.
    Izzo, T.
    Ruggiero, M. V.
    LEUKEMIA RESEARCH, 2007, 31 : S63 - S64
  • [10] Analysis of Immune-Cell Distribution of Bone Marrow in Patients with Myelodysplastic Syndrome
    Lin, Chun-Liang
    Lin, Ching-Chan
    Chen, Tzu-Ting
    Lo, Wen-Jyi
    Tzeng, Shu-Ling
    HEMATOLOGY REPORTS, 2023, 15 (01) : 50 - 56
12345